N K Bhat

1.2k total citations
22 papers, 1.1k citations indexed

About

N K Bhat is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, N K Bhat has authored 22 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in N K Bhat's work include Ubiquitin and proteasome pathways (6 papers), Cancer-related Molecular Pathways (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). N K Bhat is often cited by papers focused on Ubiquitin and proteasome pathways (6 papers), Cancer-related Molecular Pathways (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). N K Bhat collaborates with scholars based in United States, Cameroon and Canada. N K Bhat's co-authors include Shigeyoshi Fujiwara, Robert J. Fisher, Bhupendra Singh, Takis S. Papas, Richard Ascione, T S Papas, Anwesha Chatterjee, Amruta Ronghe, Shigeki Koizumi and T S Papas and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

N K Bhat

21 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N K Bhat United States 16 762 291 229 201 132 22 1.1k
Akiyuki Hada Japan 18 936 1.2× 186 0.6× 182 0.8× 181 0.9× 91 0.7× 23 1.5k
Jacqueline M. Glynn United States 8 742 1.0× 326 1.1× 108 0.5× 310 1.5× 149 1.1× 8 1.1k
Monique C.A. Duyndam Netherlands 13 623 0.8× 128 0.4× 249 1.1× 233 1.2× 102 0.8× 18 931
Narayan Bhat United States 16 1.5k 2.0× 301 1.0× 135 0.6× 203 1.0× 169 1.3× 30 1.9k
Ulrich Pessara Germany 13 541 0.7× 411 1.4× 225 1.0× 157 0.8× 67 0.5× 17 1.1k
Steven Bossone United States 7 985 1.3× 132 0.5× 121 0.5× 234 1.2× 142 1.1× 8 1.2k
A. Lazaris-Karatzas Canada 10 1.8k 2.4× 191 0.7× 145 0.6× 254 1.3× 136 1.0× 11 2.1k
Hyang‐Sook Yoo South Korea 22 898 1.2× 114 0.4× 275 1.2× 151 0.8× 141 1.1× 43 1.1k
Nicholas Grammatikakis United States 18 1.3k 1.7× 299 1.0× 99 0.4× 229 1.1× 69 0.5× 22 1.6k
Gitte P. Ratz Denmark 14 913 1.2× 240 0.8× 127 0.6× 100 0.5× 66 0.5× 17 1.2k

Countries citing papers authored by N K Bhat

Since Specialization
Citations

This map shows the geographic impact of N K Bhat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N K Bhat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N K Bhat more than expected).

Fields of papers citing papers by N K Bhat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N K Bhat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N K Bhat. The network helps show where N K Bhat may publish in the future.

Co-authorship network of co-authors of N K Bhat

This figure shows the co-authorship network connecting the top 25 collaborators of N K Bhat. A scholar is included among the top collaborators of N K Bhat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N K Bhat. N K Bhat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Singh, Bhupendra, et al.. (2013). MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis. Carcinogenesis. 34(5). 1165–1172. 174 indexed citations
3.
Cheng, Robert Y.S., et al.. (2004). Expressions of hepatic genes, especially IGF-binding protein-1, correlating with serum corticosterone in microarray analysis. Journal of Molecular Endocrinology. 32(1). 257–278. 12 indexed citations
4.
Ratnasinghe, D, Joseph A. Tangrea, Claudia Stewart, et al.. (2001). Influence of antioxidants and the CYP1A1 isoleucine to valine polymorphism on the smoking--lung cancer association.. PubMed. 21(2B). 1295–9. 5 indexed citations
5.
Romano-Spica, V., et al.. (2000). Ets1 oncogene induction by ELF-modulated 50 MHz radiofrequency electromagnetic field. Bioelectromagnetics. 21(1). 8–18. 15 indexed citations
6.
Woodson, K., D Ratnasinghe, N K Bhat, et al.. (1999). Prevalence of disease-related DNA polymorphisms among participants in a large cancer prevention trial. European Journal of Cancer Prevention. 8(5). 441–448. 26 indexed citations
7.
Romano-Spica, V., Panagiotis Georgiou, Hidenori Suzuki, T S Papas, & N K Bhat. (1995). Role of ETS1 in IL-2 gene expression.. The Journal of Immunology. 154(6). 2724–2732. 35 indexed citations
8.
Suzuki, Hiroaki, V. Romano-Spica, T S Papas, & N K Bhat. (1995). ETS1 suppresses tumorigenicity of human colon cancer cells.. Proceedings of the National Academy of Sciences. 92(10). 4442–4446. 36 indexed citations
9.
Mavrothalassitis, George, et al.. (1993). Human ERG-2 protein is a phosphorylated DNA-binding protein--a distinct member of the ets family.. PubMed. 8(6). 1559–66. 41 indexed citations
10.
Lin, J X, et al.. (1993). Characterization of the human interleukin-2 receptor beta-chain gene promoter: regulation of promoter activity by ets gene products.. Molecular and Cellular Biology. 13(10). 6201–6210. 64 indexed citations
11.
Romano-Spica, V., et al.. (1993). CHARACTERIZATION OF ECTOPICALLY-EXPRESSED ETS1 IN HUMAN COLON-CANCER CELLS - INDUCTION OF PUTATIVE ETS1-TARGET GENE. International Journal of Oncology. 3(4). 565–73. 6 indexed citations
12.
Fisher, R.J., Shigeki Koizumi, Akiko Kondoh, et al.. (1992). Human ETS1 oncoprotein. Purification, isoforms, -SH modification, and DNA sequence-specific binding.. Journal of Biological Chemistry. 267(25). 17957–17965. 35 indexed citations
13.
14.
Yoganathan, Thillainathan, N K Bhat, & B.H. Sells. (1992). A positive regulator of the ribosomal protein gene, β factor, belongs to the ETS oncoprotein family. Biochemical Journal. 287(2). 349–353. 25 indexed citations
15.
Bristol, Lynn A., Mitchell R. Smith, N K Bhat, & Scott K. Durum. (1991). IL-1 induces ornithine decarboxylase in normal T lymphocytes. The Journal of Immunology. 146(5). 1509–1515. 8 indexed citations
16.
Bhat, N K, Kristin L. Komschlies, Shigeyoshi Fujiwara, et al.. (1989). Expression of ets genes in mouse thymocyte subsets and T cells.. The Journal of Immunology. 142(2). 672–678. 113 indexed citations
17.
Fisher, Robert J., Shigeyoshi Fujiwara, N K Bhat, Clifford W. Schweinfest, & Takis S. Papas. (1989). c-ets-2 and the Mitogenic Signal Pathway. Hämatologie und Bluttransfusion. 32. 441–448.
18.
Papas, Takis S., Robert J. Fisher, N K Bhat, et al.. (1989). The ets Family of Genes: Molecular Biology and Functional Implications. Current topics in microbiology and immunology. 149. 143–147. 13 indexed citations
19.
Fujiwara, Shigeyoshi, Robert J. Fisher, N K Bhat, Susana Moreno Dı́az de la Espina, & Takis S. Papas. (1988). A short-lived nuclear phosphoprotein encoded by the human ets-2 proto-oncogene is stabilized by activation of protein kinase C.. Molecular and Cellular Biology. 8(11). 4700–4706. 37 indexed citations
20.
Bhat, N K, Robert J. Fisher, Shigeyoshi Fujiwara, Richard Ascione, & T S Papas. (1987). Temporal and tissue-specific expression of mouse ets genes.. Proceedings of the National Academy of Sciences. 84(10). 3161–3165. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026